In the AI Risk Reward podcast, our host,
Alec Crawford, Founder and CEO of Artificial Intelligence Risk, Inc. aicrisk.com , interviews guests about balancing the risk and reward of Artificial Intelligence for you, your business, and society as a whole. Podcast production and sound engineering by Troutman Street Audio. You can find them on LinkedIn.
In this episode, Alec speaks with Javier Tordable, CEO and Founder of Pauling.AI, about the transformative potential of AI in drug discovery. Javier shares his journey from mathematics and technology roles at Microsoft and Google to launching Pauling.AI, highlighting the importance of innovation and mentorship in shaping his career. He explains how Pauling.AI aims to automate the process of moving from scientific hypothesis to molecule testing, thereby accelerating and reducing the cost of bringing new medicines to market. The discussion covers the ethical considerations of AI in life sciences, the realistic risks of misuse, and the challenges posed by today’s advanced content generation capabilities. Javier also provides practical advice for pharma CEOs considering AI adoption and reflects on the evolving role of regulators in healthcare and technology.
